Methods and kits to improve the fluorescent signal of DMB-labeled sialic acids
AssigneeAgilent Technologies, Inc.
InventorFrancis T. Haxo
Life of this patent
Estimating the term…
Loading patent…
AssigneeAgilent Technologies, Inc.
InventorFrancis T. Haxo
Estimating the term…
The invention relates to a method and a kit for stably detecting sialic acid by an enzyme method. The method comprises the following steps of: generating N-acetylneuraminic acid from bound sialic acid under the catalysis of neuraminic acid aldolase; transforming the N-acetylneuraminic acid into N-acetylmannosamine under the catalysis of neuraminidase; reacting the product with mannosamine dehydrogenase and nicotinamide adenine dinucleotide (NAD) to generate reduced nicotinamide adenine dinucleotide (NADH); and measuring the sialic acid content by detecting the amount of the generated NADH. The invention also relates to the kit prepared according to the method. The method and the kit are conveniently and quickly used, the sialic acid is not required to be redissolved by dissolving liquid, is stable for a long time and has small inter-bottle variation, the method and the kit are suitable for various biochemical analyzers, secondary pollution is avoided, and a production process method is simplified.
An in vitro method for labeling free sialic acids with 1, 2-diamino-4, 5-methylenedioxybenzene (“DMB”) and, optionally, for analyzing said DMB-labeled sialic acids, said method comprising step (a) incubating said free sialic acids with an effective amount of DMB in an aqueous solution comprising (i) an aqueous solution of glycine and an acid, wherein said glycine is present in a molarity of 0.25M to 3M and said solution has a pH of 1.5-3.2, and (ii) a reductant selected from thioglycerol and β-mercaptoethanol (“BME”),
A method of releasing, labeling and, optionally, analyzing, sialic acids present on a glycoconjugate, said method comprising
Dependencies are inferred from the claim text.